Family Dermatology: Contractor Referrals to the In-House Pathology Lab

Whistleblower Justice Network

In the Family Dermatology Stark settlement, the company agreed to pay $3,247,835 to resolve allegations that improper financial relationships with dermatologist contractors led to Medicare claims for in-house pathology work. For a physician, practice manager or billing employee, the revealing detail is the connection between the practice contract and the destination of the specimens. The whistleblower’s complaint described purchase money, continuing compensation and software pricing as ways to direct that business to the same laboratory.

The Justice Department announced the settlement on April 21, 2015. Family Dermatology operated dermatology practices throughout the Eastern United States and a Georgia pathology laboratory under the name Nelson Dermatopathology. The government alleged that the company routinely required dermatologist contractors to use that laboratory and improperly billed Medicare for analyses of the specimens they sent.

Buying the Physician Practice and Directing the Pathology

The whistleblower’s complaint alleged that Family Dermatology bought practices, kept the selling dermatologists working as independent contractors and required them to send their pathology work to Nelson Dermatopathology. It described contractor compensation based on a percentage of the practice’s net collections. In the complaint’s account, the practice sale and the continuing work agreement put the buyer on both sides of the physician’s income.

The physician who brought this complaint described a $450,000 purchase obligation structured as a loan from the seller to Family Dermatology, repayable within four years. His professional-services agreement, according to the complaint, provided compensation of 45% and up to 60% of his net collections. Shortly after the agreements were signed, an executive allegedly told him to send all pathology tests from his practice to the laboratory in Atlanta.

The complaint’s physician kickback allegations centered on purchase money and compensation intended to induce referrals of services paid for by Medicare and Medicaid. It also alleged that the arrangement directed thousands of dermatopathology services to the laboratory, including many paid for by those programs. In that account, the money for buying a practice and the money earned from testing its patients’ specimens belonged to the same referral story.

Software Pricing Tied to the Laboratory

The complaint described another route to the same specimens through Databased, a company selling practice-management and electronic medical-records software to dermatology practices. Its customers allegedly included practices outside Family Dermatology’s ownership. The alleged referral demand could therefore reach beyond the practices the company had bought.

The whistleblower alleged that the software was offered at a steep discount, followed by a demand once practices depended on it:

After a few months, once these dermatology practices have become completely reliant upon Defendant Databased’s Practice Management and Electronic Medical Records System, [the executive] would inform these practices that the price for continuing to use the Databased system will immediately increase by 85% unless they agree to refer their pathology services to [the laboratory owner] and Nelson Dermatopathology and Pathology Laboratory.

United States ex rel. Ross v. Family Dermatology of Pennsylvania, P.C., et al., whistleblower’s complaint, paragraph 77

The complaint also quoted an executive’s email explaining that the laboratory subsidized software for customers who sent it a substantial portion of their pathology work. It alleged that practices accepted the referral demand because losing software access would disrupt their operations and income. We see a referral demand dressed up as a software discount: in the complaint’s account, the price of running the office depended on where the doctor sent the specimen. The complaint connected the resulting referrals to services paid for by Medicare and Medicaid.

How Does the Stark Law Affect Physician Self-Referrals?

The Stark Law limits where doctors can refer Medicare patients for certain services when they have financial ties to the receiving business, unless an exception applies. As CMS explains the referral restrictions, the law also bars billing for services from prohibited referrals. In Family Dermatology’s case, the government alleged improper physician financial relationships and Medicare claims for the pathology analyses those referrals produced.

The complaint challenged whether the purchased practices qualified for the in-office ancillary services exception. It alleged that acquired practices continued billing under individual physician provider numbers, with payments directed to the laboratory owner in Atlanta. It also alleged that compensation remained individualized to each practice rather than pooled across the affiliated practices.

The whistleblower alleged that the purchased offices did not operate as a single group practice. For an insider, the useful connection is between the arrangement described in the agreements and the identities appearing on the actual claims.

Why the Referral Destination Matters

A financial interest can affect both how many services a physician recommends and where patients receive them. The Robert Wood Johnson Foundation’s 2008 research synthesis, Physician Self-Referral and Physician-Owned Specialty Facilities, describes both incentives and reports earlier research finding higher referral rates among physicians who owned laboratory or physical-therapy facilities.

In the Family Dermatology complaint, that context was a practice purchase, a continuing services agreement, a software dependency and a laboratory destination. Those allegations explain why we look across the business when examining a referral arrangement. The physician’s order connects to decisions made in contracting, software sales and billing.

Three Whistleblower Suits, One Settlement

The Family Dermatology settlement resolved allegations raised in three separate qui tam suits brought by three whistleblowers. The Justice Department announced a collective whistleblower reward from the recovery, alongside the company’s obligation to pay the United States.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Here, a physician’s account of a proposed practice sale and a laboratory-routing demand supplied details that a Medicare claim alone would never explain.

Purchase Prices and Bonuses Can Carry the Same Incentive

The referral connection also appeared in the separate Oliver Street Dermatology Management case, involving the business known as U.S. Dermatology Partners. In its September 2023 settlement announcement, the Justice Department alleged that purchase prices for dermatology practices had been increased in exchange for referrals to affiliated businesses, with resulting Medicare claims. That comparison puts the acquisition payment itself in view when examining what a buyer expected from a selling physician.

At Northwest Anesthesiology and Pain Services, the alleged connection sat in laboratory-referral bonuses. The Justice Department’s January 2025 settlement announcement described bonuses allegedly based on laboratory referrals less costs and fees, rather than the practice productivity specified in the contracts. Across these arrangements, we examine what determines the payment and what business follows it.

What the Contracts, Specimens and Claims Connect

The evidence of physician billing fraud in an arrangement like this crosses the practice, the software business and the laboratory. The contracts explain what the physician stood to earn, while pathology orders and claims connect the referral demand to government payments.

For the software allegation, the price notice and subsidy terms explain what changed when a practice selected a laboratory. Billing identities and provider-number records address the complaint’s claim that the offices did not function as one group. You may see that connection from the practice office, the software business or the laboratory. We work with you to understand how your knowledge fits the claims.

You Know Why the Specimens Went There

If you saw a practice sale, compensation agreement or software discount tied to laboratory referrals, speak to one of our Whistleblower Experts about why the specimens went there. We connect your knowledge of the business to the government claims and bring in physician self-referral whistleblower lawyers who understand practice and laboratory relationships. We stay beside you throughout the process to build your strongest physician self-referral whistleblower case.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365